Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Dexcom Inc (DXCM)

Dexcom Inc (DXCM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
DexCom's Margin Guidance Held Steady Despite Growth Acceleration—Confidence or Caution Ahead? Barchart - Wed Jul 29, 4:08PM CDT

Barchart Research What to Expect from DXCM Earnings DXCM Generated July 29, 2026 Current Price $75.14 EPS Estimate $$0.61 Consensus Rating Strong Buy Average Move 12.40% DexCom's Margin Guidance Held Steady...

DXCM : 75.14 (+0.39%)
DXCM
DexCom Earnings: What To Look For From DXCM StockStory - Tue Jul 28, 10:22PM CDT

DexCom Earnings: What To Look For From DXCM

DXCM : 75.14 (+0.39%)
Kaskela Law Firm Announces Investigation of DexCom, Inc. (DXCM) and Encourages Long-Term DXCM Shareholders with Investment Losses to Contact the Firm Business Wire - Thu Jul 23, 6:00AM CDT

Investor litigation firm Kaskela Law announces that it is investigating DexCom, Inc. (Nasdaq: DXCM) on behalf of the company’s long-term investors. ...

DXCM : 75.14 (+0.39%)
Dexcom Announced as First Participant Selected for FDA's TEMPO Digital Health Devices Pilot Program Business Wire - Wed Jul 22, 4:15PM CDT

Participation advances the company’s vision and regulatory pathway for earlier intervention, screening for prediabetes and Type 2 diabetes and empowerment

DXCM : 75.14 (+0.39%)
Next-Generation Diabetes Therapies Are Reshaping Healthcare and Creating MultiBillion-Dollar Revenue Opportunities FinancialNewsMedia - Tue Jul 21, 7:29AM CDT

EQNX::TICKER_START (OTCQB:AVAI),(NYSE:NVO),(NASDAQ:SNY),(NASDAQ:DXCM),(NASDAQ:TNDM) EQNX::TICKER_END

AVAI : 0.1300 (-16.13%)
TNDM : 18.59 (+4.67%)
NVO : 51.58 (+1.22%)
DXCM : 75.14 (+0.39%)
SNY : 44.85 (-1.52%)
SNOW
2 Cash-Heavy Stocks on Our Buy List and 1 We Avoid StockStory - Mon Jul 20, 11:35PM CDT

2 Cash-Heavy Stocks on Our Buy List and 1 We Avoid

SNOW : 282.90 (+4.64%)
WRBY : 26.03 (+0.12%)
DXCM : 75.14 (+0.39%)
BIIB
1 Mid-Cap Stock to Target This Week and 2 We Find Risky StockStory - Mon Jul 13, 11:33PM CDT

1 Mid-Cap Stock to Target This Week and 2 We Find Risky

AFG : 143.51 (-0.94%)
DXCM : 75.14 (+0.39%)
BIIB : 209.23 (+1.76%)
Dexcom G7 15 Day Receives Health Canada Authorization: Extending Wear and Continuity for Canadian Adults Living with Diabetes Business Wire - Mon Jul 13, 3:45PM CDT

Dexcom G7 15 Day is the longest‑lasting and most accurate 1-4 CGM system authorized by Health Canada, providing real-time glucose readings for an industry-leading 15.5 days ...

DXCM : 75.14 (+0.39%)
Dexcom Schedules Second Quarter 2026 Earnings Release and Conference Call for July 30, 2026 at 4:30 p.m. Eastern Time Business Wire - Thu Jul 9, 7:30AM CDT

DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its second quarter 2026 financial results after market close on Thursday, July 30, 2026. Management will hold a conference call...

DXCM : 75.14 (+0.39%)
Female scientist using microscope making lab analysis by aFotostock via Adobe Stock
Earnings Preview: What To Expect From DexCom's Report Barchart - Mon Jul 6, 5:51AM CDT

DexCom is expected to announce its second-quarter earnings soon, and Wall Street expects the company’s EPS to increase by a double-digit percentage.

XLV : 166.24 (-0.61%)
$SPX : 7,316.15 (-1.52%)
DXCM : 75.14 (+0.39%)

Barchart Exclusives

This Dividend Stock Is Up 22% in a Month Despite Mixed Q2 Earnings. Don’t Sell Just Yet. Barchart - Wed Jul 29, 6:30PM CDT
Domino’s Pizza stock has rebounded sharply from its 2026 lows. While its valuation multiples have expanded and DPZ does not look as tempting now, dividend investors can stay put in the stock. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.